Recombinant Human CD14 protein (His tag)

A DNA sequence encoding the Human sCD14 protein (P08571) (Met1-Met344) was expressed with a C-His.

Introducing the Recombinant Human CD14 Protein (His Tag), a cutting-edge product meticulously engineered to cater to the diverse needs of the scientific community. This protein, derived from human sources, boasts a high level of purity and is equipped with a His tag for enhanced detection and purification capabilities.

The Recombinant Human CD14 Protein (His Tag) is a paramount tool in various research applications, particularly in the field of immunology. Its ability to bind to lipopolysaccharides (LPS) with utmost specificity and affinity renders it an invaluable asset in studying innate immune responses and deciphering the intricate mechanisms underlying pathogen recognition.

Crafted with utmost precision, this protein exhibits exceptional stability and solubility, ensuring optimal performance in a wide range of experimental conditions. Its recombinant nature guarantees batch-to-batch consistency, enabling reliable and reproducible results, thus elevating the scientific rigor of your investigations.

Furthermore, the inclusion of the His tag facilitates facile purification, streamlining the workflow and expediting downstream applications. This tag, renowned for its affinity towards immobilized metal affinity chromatography (IMAC) matrices, enables rapid and efficient isolation of the Recombinant Human CD14 Protein, thereby minimizing laborious purification steps and maximizing productivity.

The Recombinant Human CD14 Protein (His Tag) is supplied in a lyophilized form, ensuring long-term stability and ease of storage. With its exceptional quality and performance, this product is poised to revolutionize your research endeavors, empowering you to unravel the complexities of the immune system and pave the way for groundbreaking discoveries.

Choose the Recombinant Human CD14 Protein (His Tag) and embark on a transformative scientific journey, where precision, reliability, and innovation converge to redefine the boundaries of knowledge.